Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients. A systematic review and meta-analysis

DSpace Repositorium (Manakin basiert)

Zur Kurzanzeige

dc.contributor.author Chatziioannou, Eftychia
dc.contributor.author Durak, Derya
dc.contributor.author Frey, Georg
dc.contributor.author Serna Higuita, Lina María
dc.contributor.author Rasch, Marie-Lena
dc.contributor.author Flatz, Lukas
dc.contributor.author Amaral, Teresa
dc.contributor.author Leiter-Stöppke, Ulrike
dc.date.accessioned 2026-01-27T07:41:32Z
dc.date.available 2026-01-27T07:41:32Z
dc.date.issued 2025
dc.identifier.issn 1664-3224
dc.identifier.uri http://hdl.handle.net/10900/174340
dc.language.iso en de_DE
dc.publisher Lausanne : Frontiers Media Sa de_DE
dc.relation.uri http://dx.doi.org/10.3389/fimmu.2025.1524945 de_DE
dc.subject.ddc 570 de_DE
dc.subject.ddc 610 de_DE
dc.title Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients. A systematic review and meta-analysis de_DE
dc.type Article de_DE
utue.quellen.id 20250630000000_01935
utue.personen.roh Lallas, Konstantinos
utue.personen.roh Chatziioannou, Eftychia
utue.personen.roh Durak, Derya
utue.personen.roh Frey, Georg
utue.personen.roh Serna-Higuita, Lina Maria
utue.personen.roh Rasch, Marie-Lena
utue.personen.roh Kyrgidis, Athanassios
utue.personen.roh Timotheadou, Eleni
utue.personen.roh Apalla, Zoe
utue.personen.roh Leiter, Ulrike
utue.personen.roh Flatz, Lukas
utue.personen.roh Lallas, Aimilios
utue.personen.roh Amaral, Teresa
dcterms.isPartOf.ZSTitelID Frontiers in Immunology de_DE
dcterms.isPartOf.ZS-Issue Article 1524945 de_DE
dcterms.isPartOf.ZS-Volume 16 de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Dateien zu dieser Ressource

Dateien Größe Format Anzeige

Zu diesem Dokument gibt es keine Dateien.

Das Dokument erscheint in:

Zur Kurzanzeige